Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Freeze dried powder injection of hirudin and its preparation method

A technology for freeze-dried powder injection and hirudin, which is applied in the field of hirudin freeze-dried powder for injection and its preparation, can solve the problems of reduced inhibition constant, high environmental requirements, low purity of hirudin, etc. Effect

Inactive Publication Date: 2005-01-26
北京干露春科技有限公司
View PDF1 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, there have been more and more studies on recombinant hirudin. However, compared with natural hirudin, recombinant hirudin has two congenital defects: on the one hand, although recombinant hirudin is extremely similar to natural hirudin in amino acid sequence and structure Similar, but the deletion of the sulfate group on the 63-position tyrosine residue makes the inhibitory constant of recombinant hirudin to thrombin 90% lower than that of natural hirudin; on the other hand, an important reason is that hirudin is a good drug The effect is not only the effect of hirudin, but also the participation of other active ingredients in leech saliva.
[0004] The patent application number 03113566 discloses a method for extracting and purifying hirudin, which is to extract hirudin with acetone from the saliva secretion of living leeches, and then purify with column chromatography. The use of organic solvents makes the environmental requirements particularly high, and only anion exchange column chromatography (gel filtration column chromatography is only the effect of molecular sieves) is used for purification, the impurities are not completely separated, the purity of hirudin is not high, and this patent has not been seen Reports on the purity of hirudin; the patent application number 95117701 discloses the use of affinity chromatography to purify hirudin, but in the actual application process, it is only suitable for laboratories and cannot be further scaled up and produced in pilot scales, which is not conducive to industrialization.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Freeze dried powder injection of hirudin and its preparation method
  • Freeze dried powder injection of hirudin and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Detection of specific activity of hirudin

[0028] 1. Experimental principle: The detection method of natural hirudin activity has not yet been published. According to the detection method of thrombin activity (Appendix 1 of the 2000 edition of the Chinese Biological Products Regulations), the ratio of hirudin and thrombin is 1:1. According to the principle of consuming one thrombin unit, which is equivalent to one anticoagulant unit (ATU), the potency of the anticoagulant unit of hirudin is detected by the test tube method (serial dilution method).

[0029] 2. Experimental materials: normal saline solution of 5g / L fibrinogen, normal saline for injection (provided by the laboratory of Beijing Qianluchun Technology Co., Ltd.)

[0030] Freeze-dried thrombin (purchased by Anhui Kuwahara Institute of Biotechnology, the content of each bottle is 500IU, diluted with normal saline to contain 0.5IU of thrombin per ml)

[0031] 3. Sample to be tested: the hirudin sample is the ...

Embodiment 2

[0039] The effect on thrombus formation in rats was determined by thrombus method.

[0040] 1. Experimental drug: normal saline (blank group) was provided by the laboratory of Beijing Qianluchun Technology Co., Ltd.

[0041] Leech Injection (Provided by Jilin Provincial Institute of Materia Medica)

[0042] Hirudin freeze-dried powder injection of the present invention (provided by the laboratory of Beijing Ganluchun Science and Technology Co., Ltd.)

[0043] 2. Experimental animals: 30 rats weighing 300-400 grams, male or female. Divide into three groups, 10 in each group.

[0044] 3. Experimental method: Rats were anesthetized (sodium pentobarbital 30-40mg / kg, ip), fixed in the supine position, the trachea was separated, a plastic cannula was inserted, and the right common carotid artery and left external jugular vein were separated. A 6 cm long silk thread was placed in the middle of the polyethylene tube, and the polyethylene tube was filled with...

Embodiment 3

[0049] Effect on ADP-induced thrombotic death in mice

[0050] Medicine: Freeze-dried powder injection of the present invention (provided by the laboratory of Beijing Ganluchun Technology Co., Ltd.)

[0051] Commercially available Ginkgo Damo injection (produced by Nanjing Jinling Pharmaceutical Co., Ltd., purchased from Beijing Baitasi Pharmaceutical Wholesale Company)

[0052] Normal saline (provided by the laboratory of Beijing Qianluchun Technology Co., Ltd.)

[0053] Method: Take 60 healthy mice, half male and half male, and randomly divide them into 3 groups: normal saline group, the freeze-dried powder injection group of the present invention, and the commercially available Ginkgo Damo injection group. Daily tail vein administration, continuous 7d, at the last time 1 hour after administration, ADP48.0mL / kg was injected into the tail vein, and the animal death was recorded. See Table 2:

[0054] group

Total / only

Number of deaths / only

d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Ionic strengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a freeze dry injection of hirudin and its preparation process. It is characterized in that hirudin is extracted from fresh leech, pharmaceutic adjuvant can be added or not added after purification to prepare freeze dry injection formulation of hirudin, the character also lies in not adopting any organic solvent in the preparation method, but adopting purification methods of ultra filtration, ion exchange column chromatography and reverse osmosis condensation to get hirudin with comparative highly purity. The pharmacody experiment result indicates that the freeze dry injection has a favorable pharmacological action.

Description

Technical field [0001] The invention belongs to the technical field of traditional Chinese medicine pharmacy, and in particular relates to a hirudin freeze-dried powder injection and a preparation method thereof. Background technique [0002] Leech is a traditional Chinese medicine in my country, which was recorded in "Shen Nong's Materia Medica" 1800 years ago. Traditional Chinese medicine believes that it has the effects of breaking blood, expelling blood stasis, and dredging menstrual flow. It is mainly used to treat lumps, lumps, blood stasis, amenorrhea, and bruises. In the West, leeches are also commonly used to suck blood to treat certain diseases. A variety of active ingredients have been extracted from leeches and their salivary glands, among which hirudin is the most active and most researched ingredient. It is a small molecular protein (polypeptide) composed of 65-66 amino acids. Hirudin has a strong inhibitory effect on thrombin, and is the strongest natural sp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/19A61K38/58A61P7/02
Inventor 倪大石张正生
Owner 北京干露春科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products